Cervical Insufficiency Clinical Presentation

1. Practice bulletin no. 142: cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014 Feb. 123(2 Pt 1):372-9. [Medline].

2. Iams JD, Goldenberg RL, Meis PJ, Mercer BM, Moawad A, Das A, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med. 1996 Feb 29. 334(9):567-72. [Medline].

3. Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol. 2008 May. 31(5):579-87. [Medline].

4. Gomez R, Romero R, Medina L, Nien JK, Chaiworapongsa T, Carstens M. Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes. Am J Obstet Gynecol. 2005 Feb. 192(2):350-9. [Medline].

5. Schmitz T, Maillard F, Bessard-Bacquaert S, Kayem G, Fulla Y, Cabrol D, et al. Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor. Am J Obstet Gynecol. 2006 Jan. 194(1):138-43. [Medline].

6. Berghella V, Ludmir J, Simonazzi G, Owen J. Transvaginal cervical cerclage: evidence for perioperative management strategies. Am J Obstet Gynecol. 2013 Sep. 209(3):181-92. [Medline].

7. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003 Jun 12. 348(24):2379-85. [Medline].

8. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol. 2003 Feb. 188(2):419-24. [Medline].

9. O'Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2007 Oct. 30(5):687-96. [Medline].

10. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med. 2007 Aug 2. 357(5):462-9. [Medline].

11. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011 Jul. 38(1):18-31. [Medline]. [Full Text].

12. Dharan VB, Ludmir J. Alternative treatment for a short cervix: the cervical pessary. Semin Perinatol. 2009 Oct. 33(5):338-42. [Medline].

13. Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA. Cervical pessary for preventing preterm birth. Cochrane Database Syst Rev. 2013 May 31. 5:CD007873. [Medline].

14. Goya M, Pratcorona L, Merced C, Rodó C, Valle L, Romero A. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet. 2012 May 12. 379(9828):1800-6. [Medline].

15. Dulay, AT. Cervical Insufficiency. Merck Manual Professional: Gynecology and Obstetrics: Abnormalities of Pregnancy. Available at http://www.merckmanuals.com/professional/sec18/ch263/ch263c.html.

16. Crosby WM, Hill EC. Embryology of the Mullerian duct syytem. Review of present-day theory. Obstet Gynecol. 1962 Oct. 20:507-15. [Medline].

17. Danforth DN. The fibrous nature of the human cervix, and its relation to the isthmic segment in gravid and nongravid uteri. Am J Obstet Gynecol. 1947 Apr. 53(4):541-60. [Medline].

18. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008 Jan 5. 371(9606):75-84. [Medline].

19. Slattery MM, Morrison JJ. Preterm delivery. Lancet. 2002 Nov 9. 360(9344):1489-97. [Medline].

20. Leduc L, Wasserstrum N. Successful treatment with the Smith-Hodge pessary of cervical incompetence due to defective connective tissue in Ehlers-Danlos syndrome. Am J Perinatol. 1992 Jan. 9(1):25-7. [Medline].

21. Rackow BW, Arici A. Reproductive performance of women with müllerian anomalies. Curr Opin Obstet Gynecol. 2007 Jun. 19(3):229-37. [Medline].

22. Kaufman RH, Adam E, Hatch EE, Noller K, Herbst AL, Palmer JR. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol. 2000 Oct. 96(4):483-9. [Medline].

23. Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol. 2011 Oct. 38(4):371-82. [Medline].

24. Albrechtsen S, Rasmussen S, Thoresen S, Irgens LM, Iversen OE. Pregnancy outcome in women before and after cervical conisation: population based cohort study. BMJ. 2008 Sep 18. 337:a1343. [Medline]. [Full Text].

25. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008. 337:a1284. [Medline].

26. Noehr B, Jensen A, Frederiksen K, Tabor A, Kjaer SK. Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol. 2009 Jul. 201(1):33.e1-6. [Medline].

27. Jakobsson M, Gissler M, Paavonen J, Tapper AM. Loop electrosurgical excision procedure and the risk for preterm birth. Obstet Gynecol. 2009 Sep. 114(3):504-10. [Medline].

28. Shah PS, Zao J,. Induced termination of pregnancy and low birthweight and preterm birth: a systematic review and meta-analyses. BJOG. 2009 Oct. 116(11):1425-42. [Medline].

29. Henriet L, Kaminski M. Impact of induced abortions on subsequent pregnancy outcome: the 1995 French national perinatal survey. BJOG. 2001 Oct. 108(10):1036-42. [Medline].

30. Zilianti M, Azuaga A, Calderon F, Pagés G, Mendoza G. Monitoring the effacement of the uterine cervix by transperineal sonography: a new perspective. J Ultrasound Med. 1995 Oct. 14(10):719-24. [Medline].

31. Berghella V, Owen J, MacPherson C, Yost N, Swain M, Dildy GA 3rd. Natural history of cervical funneling in women at high risk for spontaneous preterm birth. Obstet Gynecol. 2007 Apr. 109(4):863-9. [Medline].

32. Practice bulletin no. 130: prediction and prevention of preterm birth. Obstet Gynecol. 2012 Oct. 120(4):964-73. [Medline].

33. Berghella V, Baxter JK, Hendrix NW. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database Syst Rev. 2013. 1:CD007235. [Medline].

34. Tsoi E, Fuchs IB, Rane S, Geerts L, Nicolaides KH. Sonographic measurement of cervical length in threatened preterm labor in singleton pregnancies with intact membranes. Ultrasound Obstet Gynecol. 2005 Apr. 25(4):353-6. [Medline].

35. Iams JD. Prediction and early detection of preterm labor. Obstet Gynecol. 2003 Feb. 101(2):402-12. [Medline].

36. Sotiriadis A, Papatheodorou S, Kavvadias A, Makrydimas G. Transvaginal cervical length measurement for prediction of preterm birth in women with threatened preterm labor: a meta-analysis. Ultrasound Obstet Gynecol. 2010 Jan. 35(1):54-64. [Medline].

37. Feinberg RF, Kliman HJ, Lockwood CJ. Is oncofetal fibronectin a trophoblast glue for human implantation?. Am J Pathol. 1991 Mar. 138(3):537-43. [Medline].

38. McKenna DS, Chung K, Iams JD. Effect of digital cervical examination on the expression of fetal fibronectin. J Reprod Med. 1999 Sep. 44(9):796-800. [Medline].

39. Alfirevic Z, Stampalija T, Roberts D, Jorgensen AL. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database Syst Rev. 2012 Apr 18. 4:CD008991. [Medline].

40. Berghella V, Mackeen AD. Cervical length screening with ultrasound-indicated cerclage compared with history-indicated cerclage for prevention of preterm birth: a meta-analysis. Obstet Gynecol. 2011 Jul. 118(1):148-55. [Medline].

41. Berghella V, Rafael TJ, Szychowski JM, Rust OA, Owen J. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol. 2011 Mar. 117(3):663-71. [Medline].

42. Berghella V, Keeler SM, To MS, Althuisius SM, Rust OA. Effectiveness of cerclage according to severity of cervical length shortening: a meta-analysis. Ultrasound Obstet Gynecol. 2010 Apr. 35(4):468-73. [Medline].

43. Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol. 2005 Jul. 106(1):181-9. [Medline].

44. Ehsanipoor RM, Seligman NS, Saccone G, Szymanski LM, Wissinger C, Werner EF, et al. Physical Examination-Indicated Cerclage: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015 Jul. 126 (1):125-35. [Medline].

45. Haelle T. Cerclage Linked to Higher Newborn Survival Rate. Medscape Medical News. Available at http://www.medscape.com/viewarticle/846182. June 10, 2015; Accessed: May 24, 2016.

46. Szychowski JM, Berghella V, Owen J, Hankins G, Iams JD, Sheffield JS, et al. Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-a-hydroxyprogesterone caproate. J Matern Fetal Neonatal Med. 2012 Dec. 25(12):2686-9. [Medline].

47. Nicolaides KH, Syngelaki A, Poon LC, Picciarelli G, Tul N, Zamprakou A, et al. A Randomized Trial of a Cervical Pessary to Prevent Preterm Singleton Birth. N Engl J Med. 2016 Mar 17. 374 (11):1044-52. [Medline].

48. Brown T. Cervical Pessary Does Not Reduce Early Preterm Birth. Medscape Medical News. Available at http://www.medscape.com/viewarticle/860514. March 17, 2016; Accessed: May 24, 2016.

Errol R Norwitz, MD, PhD, MBA Chief Scientific Officer, Chairman, Department of Obstetrics and Gynecology, Tufts Medical Center; Louis E Phaneuf Professor of Obstetrics and Gynecology, Tufts University School of Medicine

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Hologic, SeraCare<br/>Serve(d) as a speaker or a member of a speakers bureau for: Natera<br/>Received research grant from: Illumina<br/>Received income in an amount equal to or greater than $250 from: Natera, Illumina, Hologic, Ferring<br/>Scientific Advisory Board for: Natera, Illumina.

Kelley E Conroy, MD Maternal-Fetal Medicine Fellow, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Tufts Medical Center

Kelley E Conroy, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, Phi Beta Kappa, Society for Maternal-Fetal Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Ronald M Ramus, MD Professor of Obstetrics and Gynecology, Director, Division of Maternal-Fetal Medicine, Virginia Commonwealth University School of Medicine

Ronald M Ramus, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, Medical Society of Virginia, Society for Maternal-Fetal Medicine

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article